These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 7792749)
21. [Antithrombotic effects of molsidomine, isosorbide dinitrate and verapamil in a laser-induced thrombosis model]. Krupiński K; Breddin H; Bielawiec M Kardiol Pol; 1993 Aug; 39(8):100-4. PubMed ID: 8231003 [TBL] [Abstract][Full Text] [Related]
22. Effects of ticlopidine on von Willebrand factor-mediated shear-induced platelet activation and aggregation. Goto S; Tamura N; Sakakibara M; Ikeda Y; Handa S Platelets; 2001 Nov; 12(7):406-14. PubMed ID: 11674857 [TBL] [Abstract][Full Text] [Related]
23. Platelet activation and aggregation induced by recombinant von Willebrand factors reproducing four type 2B von Willebrand disease missense mutations. de Romeuf C; Hilbert L; Mazurier C Thromb Haemost; 1998 Jan; 79(1):211-6. PubMed ID: 9459349 [TBL] [Abstract][Full Text] [Related]
24. Platelet-vessel wall interactions in thrombosis and restenosis role of von Willebrand factor. Hoylaerts MF Verh K Acad Geneeskd Belg; 1997; 59(3):161-83. PubMed ID: 9490916 [TBL] [Abstract][Full Text] [Related]
25. Guinea pig blood: a model for the pharmacologic modulation of the GPIb/IX-vWF axis. André P; Hamaud P; Bal dit Sollier C; Drouet V; Garfinkel LI; Uzan A; Caen JP; Drouet LO Thromb Res; 1996 Jul; 83(2):127-36. PubMed ID: 8837311 [TBL] [Abstract][Full Text] [Related]
26. Binding of purified 14-3-3 zeta signaling protein to discrete amino acid sequences within the cytoplasmic domain of the platelet membrane glycoprotein Ib-IX-V complex. Andrews RK; Harris SJ; McNally T; Berndt MC Biochemistry; 1998 Jan; 37(2):638-47. PubMed ID: 9425086 [TBL] [Abstract][Full Text] [Related]
27. Multiple inhibition of platelet activation by aurintricarboxylic acid prevents vascular stenosis after endothelial injury in hamster carotid artery. Matsuno H; Kozawa O; Niwa M; Tanabe K; Ichimaru K; Takiguchi Y; Yokota M; Hayashi H; Uematsu T Thromb Haemost; 1998 Apr; 79(4):865-71. PubMed ID: 9569206 [TBL] [Abstract][Full Text] [Related]
28. Characterization of liposomes carrying von Willebrand factor-binding domain of platelet glycoprotein Ibalpha: a potential substitute for platelet transfusion. Kitaguchi T; Murata M; Iijima K; Kamide K; Imagawa T; Ikeda Y Biochem Biophys Res Commun; 1999 Aug; 261(3):784-9. PubMed ID: 10441502 [TBL] [Abstract][Full Text] [Related]
29. Effects of ultra-low-dose aspirin on embolization in a model of laser-induced thrombus formation. Doutremepuich C; Aguejouf O; Belon P Semin Thromb Hemost; 1996; 22 Suppl 1():67-70. PubMed ID: 8807732 [TBL] [Abstract][Full Text] [Related]
30. Binding of a novel 50-kilodalton alboaggregin from Trimeresurus albolabris and related viper venom proteins to the platelet membrane glycoprotein Ib-IX-V complex. Effect on platelet aggregation and glycoprotein Ib-mediated platelet activation. Andrews RK; Kroll MH; Ward CM; Rose JW; Scarborough RM; Smith AI; López JA; Berndt MC Biochemistry; 1996 Sep; 35(38):12629-39. PubMed ID: 8823201 [TBL] [Abstract][Full Text] [Related]
31. The antithrombotic effect of thromboxane receptor antagonist HN 11500 on thrombus formation in laser thrombosis model and platelet function tests. Krupiński K; Ferber H; Breddin HK; Bielawiec M Acta Haematol Pol; 1994; 25(3):235-42. PubMed ID: 7992596 [TBL] [Abstract][Full Text] [Related]
32. Antithrombotic and thrombolytic activity of heparins in a rat model of laser-induced thrombosis. Krupiński K; Giedrojć J; Breddin HK; Bielawiec M Pol J Pharmacol; 1996; 48(3):345-50. PubMed ID: 9112675 [TBL] [Abstract][Full Text] [Related]
35. Differential aspects of the glycoprotein Ib-von Willebrand factor axis in human and pig species. Zurbano MJ; Escolar G; Heras M; Ordinas A; Castillo R Haematologica; 2000 May; 85(5):514-9. PubMed ID: 10800169 [TBL] [Abstract][Full Text] [Related]
36. Effects of external electrical stimulation on laser-beam-induced experimental thrombosis. Aguejouf O; Doutremepuich F; Doutremepuich C Pathophysiol Haemost Thromb; 2006; 35(5):364-9. PubMed ID: 17230037 [TBL] [Abstract][Full Text] [Related]
37. How does agkicetin-C bind on platelet glycoprotein Ibalpha and achieve its platelet effects? Xu G; Ulrichts H; Vauterin S; De Meyer SF; Deckmyn H; Teng M; Niu L Toxicon; 2005 Apr; 45(5):561-70. PubMed ID: 15777951 [TBL] [Abstract][Full Text] [Related]
38. Recombinant von Willebrand factor fragment AR545C inhibits platelet aggregation and enhances thrombolysis with rtPA in a rabbit thrombosis model. Gurevitz O; Goldfarb A; Hod H; Feldman M; Shenkman B; Varon D; Eldar M; Inbal A Arterioscler Thromb Vasc Biol; 1998 Feb; 18(2):200-7. PubMed ID: 9484984 [TBL] [Abstract][Full Text] [Related]
39. Platelet adhesion at high shear rates: the roles of von Willebrand factor/GPIb and the beta 1 integrin alpha 2 beta 1. Gralnick HR; Kramer WS; McKeown LP; Garfinkel L; Pinot A; Williams SB; Krutzsch H Thromb Res; 1996 Jan; 81(1):113-9. PubMed ID: 8747526 [TBL] [Abstract][Full Text] [Related]
40. Unique antiplatelet effects of a novel S-nitrosoderivative of a recombinant fragment of von Willebrand factor, AR545C: in vitro and ex vivo inhibition of platelet function. Inbal A; Gurevitz O; Tamarin I; Eskaraev R; Chetrit A; Novicov I; Feldman M; Varon D; Eldar M; Loscalzo J Blood; 1999 Sep; 94(5):1693-700. PubMed ID: 10477694 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]